Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression
Article in CPT Pharmacometrics & Systems Pharmacology (March 2024)
The most recent citing publications are shown below. View all 51 publications that cite this research output on Dimensions.
Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials
Article in Journal of Cancer Research and Clinical Oncology (January 2024)
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
Article in Breast Cancer Research (January 2024)